Screening study to determine incidence of MGUS in this patient population
This study is designed to observe the incidence of monoclonal gammopathy of undetermined significance (MGUS) among obese patients planning to have weight reduction surgery or planning to enter into a physician monitored weight loss program and to follow the regression or progression of MGUS following surgery or the initiation of the weight loss program.
Study Type
OBSERVATIONAL
Enrollment
209
Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
Rate of MGUS
The primary analysis focuses on the estimation of the rate of MGUS for this specific population.
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.